The clinical course of multiple sclerosis (MS) is highly variable among patients, thus creating
important challenges for the neurologist to appropriately treat and monitor patient progress …

Background Multiple sclerosis is an inflammatory and neurodegenerative disease. People
with multiple sclerosis (pwMS) experience chronic fatigue which is difficult to deal with …

Current data emphasize the immunomodulating role of vitamin D in enhancing the anti-
inflammatory response. Vitamin D deficiency is an established risk factor for developing …

Vitamin D serum level increase is associated with a reduction in clinical relapse rate,
gadolinium-enhancing lesions, new or enlarging T2 lesions and new active lesions in the …

Abstracts Background Multiple sclerosis (MS) is an inflammatory neuro-immune disease
with a multifaceted etiology and long-lasting adverse effects. Several studies have explored …

BACKGROUND There is currently limited literature addressing the reporting of alopecia in
multiple sclerosis (MS) patients treated with disease-modifying therapies (DMTs). Anecdotal …

Abstract Background: Vitamin D (25 (OH) D) deficiency is linked to increased cardiovascular
disease (CVD) risk in the general population, but its implications for people with multiple …

Background Fatigue and disability are indicators of disease progression experienced by
many people with multiple sclerosis (pwMS). Understanding trajectories of these outcomes …

Mongolia is located at 45° north latitude in the center of the Asian continent, and about 80%
of the territory is at 1000 m above sea level. Epidemiologically, multiple sclerosis (MS) has …

Introduction: Multiple sclerosis (MS) is characterized by the destruction of the blood–brain
barrier, loss of myelin sheath, and contribution of inflammatory interleukins such as TNF …